Medicare recipients may get obesity drugs for just $149 a month under a reported White House deal in the works

marketwatch.com/story/obesity-drugs-may-get-medicare-access-under-deal-with-white-house-reports-e0472b38

The White House is close to announcing a deal with drugmakers Eli Lilly and Novo Nordisk that would cut the price of obesity drugs to $149 per month in some cases and extend coverage to certain Medicare and Medicaid beneficiaries, according to media reports Tuesday.

This story appeared on marketwatch.com, 2025-11-04 22:39:00.
The Entire Business World on a Single Page. Free to Use →